NO20082922L - Terapeutisk middel for keratokonjunktive lidelser - Google Patents
Terapeutisk middel for keratokonjunktive lidelserInfo
- Publication number
- NO20082922L NO20082922L NO20082922A NO20082922A NO20082922L NO 20082922 L NO20082922 L NO 20082922L NO 20082922 A NO20082922 A NO 20082922A NO 20082922 A NO20082922 A NO 20082922A NO 20082922 L NO20082922 L NO 20082922L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic agent
- defect
- corneal
- eprosartan
- salt
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 230000007547 defect Effects 0.000 abstract 3
- 239000002080 C09CA02 - Eprosartan Substances 0.000 abstract 2
- OROAFUQRIXKEMV-LDADJPATSA-N eprosartan Chemical compound C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 OROAFUQRIXKEMV-LDADJPATSA-N 0.000 abstract 2
- 229960004563 eprosartan Drugs 0.000 abstract 2
- 206010023332 keratitis Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010010741 Conjunctivitis Diseases 0.000 abstract 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 208000021921 corneal disease Diseases 0.000 abstract 1
- 201000007717 corneal ulcer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 206010023365 keratopathy Diseases 0.000 abstract 1
- 208000024205 superior limbic keratoconjunctivitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005351712 | 2005-12-06 | ||
| PCT/JP2006/324324 WO2007066678A1 (ja) | 2005-12-06 | 2006-12-06 | 角結膜障害治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082922L true NO20082922L (no) | 2008-06-27 |
Family
ID=38122824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082922A NO20082922L (no) | 2005-12-06 | 2008-06-25 | Terapeutisk middel for keratokonjunktive lidelser |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090270474A1 (ja) |
| EP (1) | EP1958949A4 (ja) |
| KR (1) | KR20080074128A (ja) |
| CN (1) | CN101312962A (ja) |
| CA (1) | CA2631231A1 (ja) |
| NO (1) | NO20082922L (ja) |
| RU (1) | RU2423127C2 (ja) |
| WO (1) | WO2007066678A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4412C1 (ro) * | 2014-08-29 | 2016-11-30 | Алёна ДУРНЯ | Utilizare a acidului 4-({2-butil-5-[2-carboxi-2-(tiofen-2-ilmetil)et-1-en-1-il] -1H-imidazol-1-il}metil) benzoic pentru ameliorarea elasticităţii vasculare în profilaxia complicaţiilor de geneză hipertensivă |
| WO2023034779A1 (en) * | 2021-08-31 | 2023-03-09 | The Cleveland Clinic Foundation | Topical drug treatment to prevent or reduce corneal scarring |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| DK0634175T3 (da) * | 1993-07-15 | 2001-04-30 | Hoffmann La Roche | Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist |
| JP3136352B2 (ja) * | 1996-01-22 | 2001-02-19 | 参天製薬株式会社 | 角結膜疾患治療剤 |
| US6420412B2 (en) * | 1996-03-29 | 2002-07-16 | Smithkline Beecham Corporation | Eprosartan dihydate and a process for its production and formulation |
| JPH10218792A (ja) * | 1997-02-12 | 1998-08-18 | Santen Pharmaceut Co Ltd | アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤 |
| EP0991647B1 (en) * | 1997-06-27 | 2002-09-04 | Smithkline Beecham Corporation | Eprosartan monohydrate |
| HU226948B1 (en) * | 1999-04-28 | 2010-03-29 | Takeda Pharmaceutical | Use of angiotensin ii antagonist for prevention or therapy of progression of simplex retinopathy or preproliferating retinopathy |
| JP2001031636A (ja) * | 1999-05-18 | 2001-02-06 | Senju Pharmaceut Co Ltd | α−ケトアミド誘導体およびその医薬用途 |
| JP2001058958A (ja) * | 1999-08-20 | 2001-03-06 | Senju Pharmaceut Co Ltd | 涙液分泌促進剤 |
| US20030018044A1 (en) * | 2000-02-18 | 2003-01-23 | Peyman Gholam A. | Treatment of ocular disease |
| FI114483B (fi) * | 2001-02-20 | 2004-10-29 | Jurilab Ltd Oy | Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt |
-
2006
- 2006-12-06 WO PCT/JP2006/324324 patent/WO2007066678A1/ja not_active Ceased
- 2006-12-06 RU RU2008127378/15A patent/RU2423127C2/ru not_active IP Right Cessation
- 2006-12-06 CA CA002631231A patent/CA2631231A1/en not_active Abandoned
- 2006-12-06 KR KR1020087011651A patent/KR20080074128A/ko not_active Ceased
- 2006-12-06 US US12/085,214 patent/US20090270474A1/en not_active Abandoned
- 2006-12-06 EP EP06834079A patent/EP1958949A4/en not_active Withdrawn
- 2006-12-06 CN CNA2006800437587A patent/CN101312962A/zh active Pending
-
2008
- 2008-06-25 NO NO20082922A patent/NO20082922L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2423127C2 (ru) | 2011-07-10 |
| EP1958949A4 (en) | 2010-04-28 |
| CN101312962A (zh) | 2008-11-26 |
| US20090270474A1 (en) | 2009-10-29 |
| RU2008127378A (ru) | 2010-01-20 |
| WO2007066678A1 (ja) | 2007-06-14 |
| CA2631231A1 (en) | 2007-06-14 |
| EP1958949A1 (en) | 2008-08-20 |
| KR20080074128A (ko) | 2008-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076398L (no) | Preventivt eller terapeutisk middel for keratokonjunktive forstyrrelser | |
| DE602004030470D1 (de) | Therapeutisches mittel für keratokonjunktive erkrankungen | |
| NO2020010I1 (no) | fostamatinib eller et farmasøytisk akseptabelt salt av fostamatinib, eller et hydrat, solvat eller N-oksid av fostamatinib eller det farmasøytisk akseptable saltet av fostamatinib, spesielt fostamatinib dinatrium, eventuelt på form av et hydrat | |
| PE20070241A1 (es) | Sales de 4-metil-n-[3-(4-metil-imidazo-1-lil)-5-triflurometil-fenil]-3-(4-piridi-3-nil-pirimidi-2-nilamino)-benzamida | |
| CY1118007T1 (el) | Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων | |
| PE20110598A1 (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
| NO20083568L (no) | Hydantoinforbindelser for behandling av inflammatoriske forstyrrelser | |
| DK1924264T3 (da) | Diaminopyrimidiner som p2x3- og p2x2/3-modulatorer | |
| NO20082481L (no) | Nye 2-aminoheterosykluser som er nyttige ved behandling av ABETA-relaterte patologier | |
| NO20081550L (no) | Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske | |
| CR9365A (es) | Compuestos y metodos para la inhibicion de la protein-cinasa raf | |
| NO20076691L (no) | Nanopartikulaere imatinib-mesylatformuleringer | |
| NO20076450L (no) | Heterosykliske forbindelser som nikotinsyrereseptoragonister for behandling av dyslipidemi | |
| PE20061366A1 (es) | Compuestos y composiciones como inhibidores de quinasa de proteina | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| PE20090244A1 (es) | Inhibidores de la proteina activadora de la 5-lipoxigenasa (flap) | |
| NO20076502L (no) | Pyrrolopyridiner nyttige som inhibitorer av proteinkinase | |
| NO20082674L (no) | Heterocykliske modulatorer for ATP-bindende kassett-transportere | |
| NO20082476L (no) | Bicykliske forbindelser med kinaseinhiberende aktivitet | |
| EA200601223A1 (ru) | Производные сульфонамида для лечения заболеваний | |
| NO20090910L (no) | Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister | |
| DE602006021776D1 (de) | Als kinaseinhibitoren geeignete aminopyrimidine | |
| CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
| NO20076460L (no) | Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav | |
| EA200800201A1 (ru) | Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |